Esperion Therapeutics Cash from Financing (TTM) Insights

Esperion Therapeutics Inc (ESPR)

2.09 +0.18 (+9.42%) USD | NASDAQ | Apr 23, 16:00

2.16 +0.07 (+3.35%) After-Hours: 06:03

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	50.46M
September 30, 2023	15.63M
June 30, 2023	66.24M
March 31, 2023	83.53M
December 31, 2022	32.61M
September 30, 2022	276.37M
June 30, 2022	233.74M
March 31, 2022	264.74M
December 31, 2021	268.22M
September 30, 2021	225.25M
June 30, 2021	223.20M
March 31, 2021	177.76M
December 31, 2020	201.72M
September 30, 2020	38.30M
June 30, 2020	37.68M
March 31, 2020	160.54M
December 31, 2019	136.20M
September 30, 2019	129.52M
June 30, 2019	128.42M
March 31, 2019	3.07M
December 31, 2018	10.69M
September 30, 2018	10.27M
June 30, 2018	174.46M

Date	Value
March 31, 2018	172.90M
December 31, 2017	163.46M
September 30, 2017	163.13M
June 30, 2017	-1.324M
March 31, 2017	-1.345M
December 31, 2016	-1.559M
September 30, 2016	-1.532M
June 30, 2016	-1.012M
March 31, 2016	-0.256M
December 31, 2015	190.52M
September 30, 2015	282.80M
June 30, 2015	282.81M
March 31, 2015	287.48M
December 31, 2014	97.12M
September 30, 2014	5.049M
June 30, 2014	78.35M
March 31, 2014	89.19M
December 31, 2013	89.14M
September 30, 2013	95.03M
June 30, 2013	25.62M
March 31, 2013	9.751M
December 31, 2012	15.75M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

15.63M

Minimum

Sep 2023

276.37M

Maximum

Sep 2022

144.74M

Average

136.20M

Median

Dec 2019

Cash from Financing (TTM) Benchmarks